Current Medical Science is a prominent academic journal dedicated to advancing knowledge in the fields of Medicine, Biochemistry, and Genetics. Published by SPRINGER with an ISSN of 2096-5230 and E-ISSN 2523-899X, this journal is based in China and serves as a vital resource for researchers, professionals, and students alike. With a focus on innovative research and emerging trends, Current Medical Science has established itself with an impactful presence, operating under Open Access guidelines to ensure wide dissemination of scientific findings. The journal's recognition is underscored by its impressive Scopus rankings, including a Q3 quartile placement in Biochemistry and Genetics as of 2023. It is noteworthy that the journal spans converged years from 2018 to 2024, providing a comprehensive platform for scholarly discussions and developments that drive the evolution of medical science. As it continues to publish influential research, Current Medical Science plays an essential role in bridging the gap between laboratory science and clinical application.

Journal of Clinical Practice and Research is a premier academic journal published by ERCIYES UNIV SCH MEDICINE, dedicated to advancing knowledge and research in the field of clinical practice and healthcare. With its Open Access policy since 2018, the journal fosters broad dissemination of vital research findings, allowing researchers, practitioners, and students to access high-quality articles freely. The journal aims to bridge the gap between research and practice by providing a platform for high-impact studies that explore innovative and evidence-based practices in clinical settings. As the journal continues to grow in reputation, it serves as an essential resource for professionals looking to improve clinical outcomes and enhance patient care. Based in KAYSERI, Turkiye, it welcomes contributions that reflect diverse perspectives and methodologies in clinical research to foster collaboration and knowledge sharing in the global healthcare community.

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.

Psoriasis-Targets and Therapy is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the knowledge and understanding of psoriasis treatment and management. Launched in 2011, this journal provides a platform for high-quality research that encompasses clinical studies, therapeutic advances, and novel targeted therapies for psoriasis. With a focus on the latest findings and innovative approaches, Psoriasis-Targets and Therapy serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of this dynamic field. The journal's commitment to open-access publishing ensures that critical insights and breakthroughs are readily available to the global medical community, fostering collaboration and progress in psoriasis treatment strategies. Researchers are encouraged to submit their findings to contribute to the growing body of knowledge that will ultimately improve patient care and outcomes.

The Journal of Translational Internal Medicine is a renowned platform dedicated to advancing the field of internal medicine through the dissemination of high-quality research and innovative clinical practices. Published by SCIENDO, this journal boasts a respectable Q2 ranking in the Internal Medicine category and is placed in the 69th percentile among its peers, highlighting its significant contribution to the discipline. With its ISSN 2450-131X and E-ISSN 2224-4018, the journal offers an open-access format, promoting accessibility to vital research findings for professionals and scholars around the globe. Located in Poland, the journal has been a valuable resource since its inception in 2018, and it continues to thrive through 2024 and beyond, supporting the objective of translating research into practice, enhancing patient care, and fostering collaboration among researchers and healthcare providers. This makes it an essential read for anyone invested in improving medical outcomes and understanding the evolving challenges faced in internal medicine.